HOXD13 and neoplasm: Our data also revealed a significant decrease in the number of tumor-associated macrophages (TAMs) after treatment with NDV-αCTLA-4 or NDV-sPD-1 compared to NDV-GFP, which in the latter case, showed a surprisingly significant increase in TAMs.